Impact of Monoclonal Protein at Diagnosis on Outcomes in Patients with Marginal Zone Lymphoma: A Multicenter Cohort Study
Year: 2022
Type: article
Study design: Observational Study
Source: Blood
Authors: Narendranath Epperla, Qiuhong Zhao, Lauren Shea, Reem Karmali, Pallawi Torka, Timothy Seijung Oh, Andrea Anampa-Guzman, Ximena Jordan Bruno, Elvira Umyarova, Kathryn Lindsey, Irl Brian Greenwell, Sayan Mullick Chowdhury, Yazeed Sawalha, Beth Christian, Natalie S. Grover, Nancy L. Bartlett, Adam J. Olszewski
Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Washington University in St. Louis, Northwestern University, Roswell Park Comprehensive Cancer Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Vermont, Medical University of South Carolina, MUSC Hollings Cancer Center, The Ohio State University Wexner Medical Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Brown University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310163340